凝血因子-话题@MedSci

#凝血因子#

36篇内容 | 3115人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1301019, encodeId=533b130101969, content=<a href='/topic/show?id=997b31316c5' target=_blank style='color:#2F92EE;'>#凝血因子#</a>, objectTitle=III期临床试验证实Fc融合凝血因子延长半衰期，可为血友病患者提供有效的围手术期止血, objectType=article, longId=165917, objectId=84ae16591e2f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84ae16591e2f, replyNumber=0, likeNumber=135, createdTime=2019-05-14, rootId=0, userName=lishizhe, userId=55f6293, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84ae16591e2f, moduleTitle=III期临床试验证实Fc融合凝血因子延长半衰期，可为血友病患者提供有效的围手术期止血, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84ae16591e2f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301018, encodeId=eb131301018b1, content=<a href='/topic/show?id=997b31316c5' target=_blank style='color:#2F92EE;'>#凝血因子#</a>, objectTitle=病例分享：肝硬化合并凝血因子Ⅶ缺乏, objectType=article, longId=164431, objectId=a9a21644312f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9a21644312f, replyNumber=0, likeNumber=104, createdTime=2019-04-18, rootId=0, userName=lishizhe, userId=55f6293, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9a21644312f, moduleTitle=病例分享：肝硬化合并凝血因子Ⅶ缺乏, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9a21644312f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301017, encodeId=60db130101e80, content=<a href='/topic/show?id=997b31316c5' target=_blank style='color:#2F92EE;'>#凝血因子#</a>, objectTitle=诺和诺德的长效化凝血因子VIII（ESPEROCT）获FDA批准治疗A型血友病, objectType=article, longId=160654, objectId=f5c7160654df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5c7160654df, replyNumber=0, likeNumber=89, createdTime=2019-02-22, rootId=0, userName=lishizhe, userId=55f6293, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5c7160654df, moduleTitle=诺和诺德的长效化凝血因子VIII（ESPEROCT）获FDA批准治疗A型血友病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5c7160654df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301016, encodeId=57c2130101601, content=<a href='/topic/show?id=997b31316c5' target=_blank style='color:#2F92EE;'>#凝血因子#</a>, objectTitle=凝血因子Ⅷ / Ⅸ抑制物诊断与治疗中国指南(2018年版), objectType=article, longId=155604, objectId=a6aa155604d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6aa155604d7, replyNumber=0, likeNumber=84, createdTime=2018-12-12, rootId=0, userName=lishizhe, userId=55f6293, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6aa155604d7, moduleTitle=凝血因子Ⅷ / Ⅸ抑制物诊断与治疗中国指南(2018年版), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6aa155604d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301015, encodeId=588b130101540, content=<a href='/topic/show?id=997b31316c5' target=_blank style='color:#2F92EE;'>#凝血因子#</a>, objectTitle=Blood：表观遗传老化参与调节凝血因子表达, objectType=article, longId=145154, objectId=f5f8145154fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5f8145154fd, replyNumber=0, likeNumber=64, createdTime=2018-07-27, rootId=0, userName=lishizhe, userId=55f6293, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5f8145154fd, moduleTitle=Blood：表观遗传老化参与调节凝血因子表达, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5f8145154fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301014, encodeId=db5013010146d, content=<a href='/topic/show?id=997b31316c5' target=_blank style='color:#2F92EE;'>#凝血因子#</a>, objectTitle=Critical Care：O型血病人重伤死亡率更高或与凝血因子有关, objectType=article, longId=137155, objectId=356e13e155a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=356e13e155a5, replyNumber=0, likeNumber=82, createdTime=2018-05-05, rootId=0, userName=lishizhe, userId=55f6293, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=356e13e155a5, moduleTitle=Critical Care：O型血病人重伤死亡率更高或与凝血因子有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=356e13e155a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301013, encodeId=df33130101364, content=<a href='/topic/show?id=997b31316c5' target=_blank style='color:#2F92EE;'>#凝血因子#</a>, objectTitle=Blood：促凝血因子VIIa（FVIIa），不仅促凝血，还可抗炎症！, objectType=article, longId=135845, objectId=72cf1358454e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72cf1358454e, replyNumber=0, likeNumber=98, createdTime=2018-04-21, rootId=0, userName=lishizhe, userId=55f6293, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72cf1358454e, moduleTitle=Blood：促凝血因子VIIa（FVIIa），不仅促凝血，还可抗炎症！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72cf1358454e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301012, encodeId=b0291301012e2, content=<a href='/topic/show?id=997b31316c5' target=_blank style='color:#2F92EE;'>#凝血因子#</a>, objectTitle=进口重组凝血因子主导血友病市场国产凝血因子Ⅷ增长率达50%, objectType=article, longId=135646, objectId=a0b313564611, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0b313564611, replyNumber=0, likeNumber=75, createdTime=2018-04-19, rootId=0, userName=lishizhe, userId=55f6293, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0b313564611, moduleTitle=进口重组凝血因子主导血友病市场国产凝血因子Ⅷ增长率达50%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0b313564611)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301011, encodeId=052f130101127, content=<a href='/topic/show?id=997b31316c5' target=_blank style='color:#2F92EE;'>#凝血因子#</a>, objectTitle=Blood：促血管生成的PAR2信号通路需要凝血因子VIIa整合素结合位点的参与。, objectType=article, longId=123765, objectId=bf74123e65c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf74123e65c4, replyNumber=0, likeNumber=82, createdTime=2017-12-19, rootId=0, userName=lishizhe, userId=55f6293, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf74123e65c4, moduleTitle=Blood：促血管生成的PAR2信号通路需要凝血因子VIIa整合素结合位点的参与。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf74123e65c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301010, encodeId=e579130101076, content=<a href='/topic/show?id=997b31316c5' target=_blank style='color:#2F92EE;'>#凝血因子#</a>, objectTitle=JAHA：中国学者首次揭示凝血因子V在动脉血栓形成中起关键作用！, objectType=article, longId=104593, objectId=bf921045935d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf921045935d, replyNumber=0, likeNumber=80, createdTime=2017-07-06, rootId=0, userName=lishizhe, userId=55f6293, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf921045935d, moduleTitle=JAHA：中国学者首次揭示凝血因子V在动脉血栓形成中起关键作用！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf921045935d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301009, encodeId=e9c61301009ea, content=<a href='/topic/show?id=997b31316c5' target=_blank style='color:#2F92EE;'>#凝血因子#</a>, objectTitle=Am J Obstet Gynecol：活化凝血因子Ⅶ能够减少前置胎盘产妇出血而不引起全身凝血反应！, objectType=article, longId=103998, objectId=40fa1039983c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40fa1039983c, replyNumber=0, likeNumber=101, createdTime=2017-07-01, rootId=0, userName=lishizhe, userId=55f6293, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40fa1039983c, moduleTitle=Am J Obstet Gynecol：活化凝血因子Ⅶ能够减少前置胎盘产妇出血而不引起全身凝血反应！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40fa1039983c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301008, encodeId=779513010083b, content=<a href='/topic/show?id=997b31316c5' target=_blank style='color:#2F92EE;'>#凝血因子#</a>, objectTitle=Thromb Haemost：增加人类凝血因子活性和表达的不是脂肪肝！, objectType=article, longId=99680, objectId=584c99680f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=584c99680f9, replyNumber=0, likeNumber=79, createdTime=2017-05-27, rootId=0, userName=lishizhe, userId=55f6293, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=584c99680f9, moduleTitle=Thromb Haemost：增加人类凝血因子活性和表达的不是脂肪肝！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=584c99680f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301007, encodeId=144d130100e37, content=<a href='/topic/show?id=997b31316c5' target=_blank style='color:#2F92EE;'>#凝血因子#</a>, objectTitle=Blood：定期更换凝血因子显著帮助减少血友病关节出血发生, objectType=article, longId=97488, objectId=867a9e48881, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=867a9e48881, replyNumber=0, likeNumber=122, createdTime=2017-04-30, rootId=0, userName=lishizhe, userId=55f6293, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=867a9e48881, moduleTitle=Blood：定期更换凝血因子显著帮助减少血友病关节出血发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=867a9e48881)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301006, encodeId=17f9130100644, content=<a href='/topic/show?id=997b31316c5' target=_blank style='color:#2F92EE;'>#凝血因子#</a>, objectTitle=Grifols向世界血友病联盟人道主义援助计划捐1.4亿国际单位凝血因子, objectType=article, longId=96267, objectId=f0259626e7c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0259626e7c, replyNumber=0, likeNumber=90, createdTime=2017-04-20, rootId=0, userName=lishizhe, userId=55f6293, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0259626e7c, moduleTitle=Grifols向世界血友病联盟人道主义援助计划捐1.4亿国际单位凝血因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0259626e7c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301005, encodeId=5a0b13010051f, content=<a href='/topic/show?id=997b31316c5' target=_blank style='color:#2F92EE;'>#凝血因子#</a>, objectTitle=FDA批准治疗A型血友病单链凝血因子的药物AFSTYLA, objectType=article, longId=69537, objectId=4c3d6953ec0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c3d6953ec0, replyNumber=0, likeNumber=93, createdTime=2016-06-01, rootId=0, userName=lishizhe, userId=55f6293, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c3d6953ec0, moduleTitle=FDA批准治疗A型血友病单链凝血因子的药物AFSTYLA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c3d6953ec0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301004, encodeId=60b71301004b4, content=<a href='/topic/show?id=997b31316c5' target=_blank style='color:#2F92EE;'>#凝血因子#</a>, objectTitle=ANA 2013：卒中后的凝血因子VIII水平或可预测复发事件, objectType=article, longId=25622, objectId=074b25622ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=074b25622ce, replyNumber=0, likeNumber=85, createdTime=2013-10-24, rootId=0, userName=lishizhe, userId=55f6293, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=074b25622ce, moduleTitle=ANA 2013：卒中后的凝血因子VIII水平或可预测复发事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=074b25622ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301003, encodeId=343b13010031a, content=<a href='/topic/show?id=997b31316c5' target=_blank style='color:#2F92EE;'>#凝血因子#</a>, objectTitle=SFDA：批准注射用重组人凝血因子治疗血友病, objectType=article, longId=6393, objectId=aa7663938a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa7663938a, replyNumber=0, likeNumber=97, createdTime=2012-05-21, rootId=0, userName=lishizhe, userId=55f6293, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa7663938a, moduleTitle=SFDA：批准注射用重组人凝血因子治疗血友病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa7663938a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301002, encodeId=e8451301002fa, content=<a href='/topic/show?id=997b31316c5' target=_blank style='color:#2F92EE;'>#凝血因子#</a>, objectTitle=Inspiration公司向FDA提交IB1001(重组凝血因子IX)生物制品许可申请, objectType=article, longId=5767, objectId=e6075e6789, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6075e6789, replyNumber=0, likeNumber=90, createdTime=2012-04-27, rootId=0, userName=lishizhe, userId=55f6293, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6075e6789, moduleTitle=Inspiration公司向FDA提交IB1001(重组凝血因子IX)生物制品许可申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6075e6789)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

凝血因子

2020-05-29

lishizhe (审核中...)

前往app查看评论内容

#凝血因子#

III期临床试验证实Fc融合凝血因子延长半衰期，可为血友病患者提供有效的围手术期止血

2019-05-14

lishizhe (审核中...)

前往app查看评论内容

#凝血因子#

病例分享：肝硬化合并凝血因子Ⅶ缺乏

2019-04-18

lishizhe (审核中...)

前往app查看评论内容

#凝血因子#

诺和诺德的长效化凝血因子VIII（ESPEROCT）获FDA批准治疗A型血友病

2019-02-22

lishizhe (审核中...)

前往app查看评论内容

#凝血因子#

凝血因子Ⅷ / Ⅸ抑制物诊断与治疗中国指南(2018年版)

2018-12-12

lishizhe (审核中...)

前往app查看评论内容

#凝血因子#

Blood：表观遗传老化参与调节凝血因子表达

2018-07-27

lishizhe (审核中...)

前往app查看评论内容

#凝血因子#

Critical Care：O型血病人重伤死亡率更高或与凝血因子有关

2018-05-05

lishizhe (审核中...)

前往app查看评论内容

#凝血因子#

Blood：促凝血因子VIIa（FVIIa），不仅促凝血，还可抗炎症！

2018-04-21

lishizhe (审核中...)

前往app查看评论内容

#凝血因子#

进口重组凝血因子主导血友病市场国产凝血因子Ⅷ增长率达50%

2018-04-19

lishizhe (审核中...)

前往app查看评论内容

#凝血因子#

Blood：促血管生成的PAR2信号通路需要凝血因子VIIa整合素结合位点的参与。

2017-12-19

lishizhe (审核中...)

前往app查看评论内容

#凝血因子#

JAHA：中国学者首次揭示凝血因子V在动脉血栓形成中起关键作用！

2017-07-06

lishizhe (审核中...)

前往app查看评论内容

#凝血因子#

Am J Obstet Gynecol：活化凝血因子Ⅶ能够减少前置胎盘产妇出血而不引起全身凝血反应！

2017-07-01

lishizhe (审核中...)

前往app查看评论内容

#凝血因子#

Thromb Haemost：增加人类凝血因子活性和表达的不是脂肪肝！

2017-05-27

lishizhe (审核中...)

前往app查看评论内容

#凝血因子#

Blood：定期更换凝血因子显著帮助减少血友病关节出血发生

2017-04-30

lishizhe (审核中...)

前往app查看评论内容

#凝血因子#

Grifols向世界血友病联盟人道主义援助计划捐1.4亿国际单位凝血因子

2017-04-20

lishizhe (审核中...)

前往app查看评论内容

#凝血因子#

FDA批准治疗A型血友病单链凝血因子的药物AFSTYLA

2016-06-01

lishizhe (审核中...)

前往app查看评论内容

#凝血因子#

ANA 2013：卒中后的凝血因子VIII水平或可预测复发事件

2013-10-24

lishizhe (审核中...)

前往app查看评论内容

#凝血因子#

SFDA：批准注射用重组人凝血因子治疗血友病

2012-05-21

lishizhe (审核中...)

前往app查看评论内容

#凝血因子#

Inspiration公司向FDA提交IB1001(重组凝血因子IX)生物制品许可申请

2012-04-27

科室
- - 订阅+
  - 更多科室
工具
服务